Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2025-12-05 00:00:00 ET · period of report 2025-12-05 · accession 0001468316-25-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-05 | 2025-12-05 | FENC | Raykov Rosty | Dir | S - Sale | $7.54 | -10.0K | 77.5K | -11% | -$75.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2025-12-05 | S | D | 10,000 | $7.54 | 77,526 | D | — | — | (F1) Represents shares sold pursuant to a 10b5-1 plan dated August 23, 2024. |